Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
124.07 CAD | +0.77% | +8.18% | +9.18% |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 7.71 | 6.93 | 8.67 | 10.05 | 10.06 | |||||
Return on Total Capital | 12.17 | 10.16 | 12.05 | 13.89 | 13.84 | |||||
Return On Equity % | 20.04 | 15.77 | 18.22 | 21.23 | 21.13 | |||||
Return on Common Equity | 20.04 | 15.77 | 18.22 | 21.23 | 21.13 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 24.63 | 24.02 | 24.95 | 26.79 | 26.93 | |||||
SG&A Margin | 12.95 | 12.71 | 12.12 | 11.62 | 11.33 | |||||
EBITDA Margin % | 15.17 | 15.09 | 16.15 | 18.37 | 18.96 | |||||
EBITA Margin % | 11.14 | 10.78 | 12.44 | 14.81 | 15.29 | |||||
EBIT Margin % | 11.08 | 10.71 | 12.37 | 14.75 | 15.24 | |||||
Income From Continuing Operations Margin % | 7.8 | 7.33 | 8.56 | 10.74 | 11.45 | |||||
Net Income Margin % | 7.8 | 7.33 | 8.56 | 10.74 | 11.57 | |||||
Net Avail. For Common Margin % | 7.8 | 7.33 | 8.56 | 10.74 | 11.45 | |||||
Normalized Net Income Margin | 6.62 | 6.32 | 7.43 | 9.15 | 9.76 | |||||
Levered Free Cash Flow Margin | 5.03 | 9.2 | 12.53 | 6.3 | 8.23 | |||||
Unlevered Free Cash Flow Margin | 5.47 | 9.71 | 12.95 | 6.69 | 8.6 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.11 | 1.04 | 1.12 | 1.09 | 1.06 | |||||
Fixed Assets Turnover | 3.67 | 3.41 | 3.92 | 4.02 | 3.91 | |||||
Receivables Turnover (Average Receivables) | 7.33 | 6.84 | 8.12 | 8.46 | 7.89 | |||||
Inventory Turnover (Average Inventory) | 3.11 | 3.22 | 4.03 | 3.55 | 3.15 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.83 | 2.36 | 2.59 | 2.43 | 2.64 | |||||
Quick Ratio | 0.9 | 1.43 | 1.68 | 1.43 | 1.56 | |||||
Operating Cash Flow to Current Liabilities | 0.15 | 0.44 | 0.67 | 0.21 | 0.33 | |||||
Days Sales Outstanding (Average Receivables) | 49.78 | 53.5 | 44.93 | 43.13 | 46.27 | |||||
Days Outstanding Inventory (Average Inventory) | 117.54 | 113.59 | 90.65 | 102.89 | 115.9 | |||||
Average Days Payable Outstanding | 110.29 | 98.38 | 67.87 | 64.76 | 67.74 | |||||
Cash Conversion Cycle (Average Days) | 57.03 | 68.7 | 67.71 | 81.27 | 94.43 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 44.13 | 39.56 | 34.09 | 28.85 | 25.41 | |||||
Total Debt / Total Capital | 30.62 | 28.35 | 25.42 | 22.39 | 20.26 | |||||
LT Debt/Equity | 43.5 | 39.02 | 33.69 | 28.52 | 25.07 | |||||
Long-Term Debt / Total Capital | 30.18 | 27.96 | 25.13 | 22.13 | 19.99 | |||||
Total Liabilities / Total Assets | 54.5 | 49.25 | 45.5 | 44.4 | 41.3 | |||||
EBIT / Interest Expense | 14.71 | 12.42 | 17.08 | 22.83 | 25.06 | |||||
EBITDA / Interest Expense | 20.52 | 17.86 | 22.64 | 28.76 | 31.54 | |||||
(EBITDA - Capex) / Interest Expense | 18.45 | 16.42 | 20.11 | 26.23 | 27.46 | |||||
Total Debt / EBITDA | 1.19 | 1.25 | 1.04 | 0.85 | 0.77 | |||||
Net Debt / EBITDA | 0.55 | 0.15 | -0.39 | -0.33 | -0.4 | |||||
Total Debt / (EBITDA - Capex) | 1.32 | 1.37 | 1.18 | 0.94 | 0.88 | |||||
Net Debt / (EBITDA - Capex) | 0.61 | 0.16 | -0.44 | -0.36 | -0.46 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 4.98 | -5.43 | 11.72 | 8.86 | 12.32 | |||||
Gross Profit, 1 Yr. Growth % | 4.95 | -7.77 | 16.04 | 16.89 | 11.3 | |||||
EBITDA, 1 Yr. Growth % | 9.59 | -6.77 | 19.59 | 23.81 | 13.51 | |||||
EBITA, 1 Yr. Growth % | 9.61 | -9.61 | 28.88 | 29.63 | 13.7 | |||||
EBIT, 1 Yr. Growth % | 10.26 | -9.71 | 29.13 | 29.78 | 13.75 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 13.82 | -11.12 | 30.52 | 36.51 | 17.55 | |||||
Net Income, 1 Yr. Growth % | 13.82 | -11.12 | 30.52 | 36.51 | 17.73 | |||||
Normalized Net Income, 1 Yr. Growth % | 11.99 | -10.9 | 31.37 | 34.05 | 17.71 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 13.68 | -11.46 | 29.45 | 36.75 | 17.71 | |||||
Accounts Receivable, 1 Yr. Growth % | -1.24 | 3.98 | -15.43 | 28.07 | 8.7 | |||||
Inventory, 1 Yr. Growth % | 4.43 |